Gaudium IVF & Women Health
Bidding Information
- Opens
- Feb 20, 2026
- Closes
- Feb 24, 2026
- Listing Date
- Feb 27, 2026
Company Description
The Gaudium IVF & Women Health IPO is India’s first "pure-play" fertility services company to hit the stock market. Since you're tracking this alongside other financial moves, here is the direct breakdown of the issue.
Gaudium IVF & Women Health IPO Summary
Important Dates & Timeline
The IPO is currently open for its final leg of bidding.
Opening Date: February 20, 2026
Closing Date: February 24, 2026 (Tomorrow)
Allotment Finalization: February 25, 2026
Refund Initiation: February 26, 2026
Listing Date: February 27, 2026 (BSE & NSE)
Pricing & Investment (Retail)
Price Band: ₹75 to ₹79 per equity share
Lot Size: 189 Shares
Minimum Investment: ₹14,931
Maximum Retail Investment (13 Lots): ₹1,94,103
Issue Structure
Total Issue Size: ₹165 Crore
Fresh Issue Portion: ₹90 Crore (To be used for growth and debt)
Offer for Sale (OFS): ₹75 Crore (Promoter Dr. Manika Khanna selling a portion of her 99.32% stake)
Objectives of the Fresh Issue
The company plans to utilize the ₹90 crore in fresh capital for:
Expansion: ₹50 crore for setting up 19 new IVF centers.
Debt Management: ₹20 crore for repayment or pre-payment of outstanding loans.
General Operations: Remaining funds for corporate purposes and potential FMCG product launches (mother-and-child wellness) via their subsidiary.
Quick Financial Snapshot (FY25)
Revenue from Operations: ₹70.72 Cr (Up from ₹47.89 Cr in FY24)
Profit After Tax (PAT): ₹19.13 Cr (Up from ₹10.32 Cr in FY24)
EBITDA Margin: ~40.48%
P/E Ratio: 25.3x at the upper price band
Grey Market Sentiment (GMP)
As of today, February 23, the Grey Market Premium is holding steady at approximately +₹8.5 to ₹12, indicating an estimated listing price between ₹87.5 and ₹91. This suggests a potential listing gain of roughly 11% to 15%.
Key Strengths & Risks
First Mover Advantage: No other listed peer in India specifically focused on IVF.
High Margin Business: Consistently strong EBITDA and PAT margins compared to broader healthcare chains.
Risk (Attrition): High turnover rate among skilled medical professionals (doctors and embryologists).
Risk (Legal): A significant contingent tax liability of ~₹44-45 crore, which is a large percentage of their current net worth.
Check Your Allotment Status
Verify if shares have been allocated to your application
Frequently Asked Questions
Common questions about Gaudium IVF & Women Health IPO
What is the current GMP of Gaudium IVF & Women Health IPO?
The current Grey Market Premium (GMP) of Gaudium IVF & Women Health IPO is ₹89. This indicates an expected listing gain of approximately 12.66% over the issue price of ₹79. GMP reflects unofficial market sentiment and can fluctuate based on demand and market conditions.
When is the allotment date for Gaudium IVF & Women Health IPO?
The allotment date for Gaudium IVF & Women Health IPO is Feb 26, 2026. The IPO listing is scheduled for Feb 27, 2026. You can check your allotment status on the registrar's website once the allotment is finalized.
Is Gaudium IVF & Women Health IPO good for long-term investment?
Gaudium IVF & Women Health IPO shows a current GMP of ₹89 with an expected listing gain of 12.66%. However, investment decisions should be based on your risk profile, company fundamentals, industry outlook, and financial goals. We recommend reviewing the company's DRHP, financial statements, and competitive position. Always consult with a SEBI registered financial advisor before making investment decisions.
What is the issue price and lot size of Gaudium IVF & Women Health IPO?
Gaudium IVF & Women Health IPO has an issue price of ₹79 per share with a lot size of 189 shares. The total issue size is ₹165 crores. This means the minimum investment required is ₹14,931.
Related IPOs You May Like
Explore similar upcoming and active IPOs